Table 1.

Review of previous reports on melanocytoma associated choroidal neovascularization (CNV).

Case	Chalam [3], 2006	Tran [4], 2006	Kamisasaku [5], 2012	Al-Halafi [6], 2013	Batmanabane et al. [7]	Urrets-Zavalia [8]	Rodrigues [9]	Current case
Age	Middle age	45 years	63 years	45 years	28 years	50 years	49 years	51 years
Gender	Male	-	Male	Male	Female	Male	Female	Male
Affected eye	Right	left	Left	Right	Left	Right	Left	Left
Primary presentation	Diminution of vision	Diminution of vision	Diminution of vision	Diminution of vision	Diminution of vision	Diminution of vision	Diminution of vision	Diminution of vision
Visual Acuity at 1st presentation	20/200	20/100	0.9 LogMAR	20/160	20/40	20/80	Counting fingers 50 cm	20/200
Location of choroidal neovascularization	Juxtafoveal	Peripapilla y	Adjacent to optic disc	Juxtafoveal	Peripapillary extending to the macula	Peripapillary	Macular	Peripapillary
Treatment	Photodynamic therapy	Vitrectomy and submacular surgery	Intravitreal Bevacizumab (3 injections)	Intravitreal Bevacizumab (1 injection)	Intravitreal Ranibizumab (1 injection)	Intravitreal Bevacizumab	Intravitreal anti-VEGF was recommended	Intravitreal Aflibercept (3 injections)
Follow-up	6 months	14 months	12 months	12 months	6 months	36 months	Lost to follow-	13 months